PortfoliosLab logo
BVS vs. LFMD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BVS and LFMD is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

BVS vs. LFMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bioventus Inc. (BVS) and LifeMD, Inc. (LFMD). The values are adjusted to include any dividend payments, if applicable.

-80.00%-70.00%-60.00%-50.00%-40.00%December2025FebruaryMarchAprilMay
-64.60%
-70.14%
BVS
LFMD

Key characteristics

Sharpe Ratio

BVS:

0.51

LFMD:

-0.34

Sortino Ratio

BVS:

1.92

LFMD:

0.10

Omega Ratio

BVS:

1.24

LFMD:

1.01

Calmar Ratio

BVS:

0.95

LFMD:

-0.40

Martin Ratio

BVS:

3.26

LFMD:

-0.65

Ulcer Index

BVS:

21.46%

LFMD:

52.66%

Daily Std Dev

BVS:

68.68%

LFMD:

100.09%

Max Drawdown

BVS:

-95.18%

LFMD:

-96.24%

Current Drawdown

BVS:

-64.60%

LFMD:

-73.29%

Fundamentals

Market Cap

BVS:

$486.13M

LFMD:

$336.16M

EPS

BVS:

-$0.52

LFMD:

-$0.53

PS Ratio

BVS:

0.81

LFMD:

1.58

PB Ratio

BVS:

3.15

LFMD:

107.72

Total Revenue (TTM)

BVS:

$443.82M

LFMD:

$155.19M

Gross Profit (TTM)

BVS:

$299.85M

LFMD:

$146.11M

EBITDA (TTM)

BVS:

$22.17M

LFMD:

-$2.58M

Returns By Period

In the year-to-date period, BVS achieves a -35.24% return, which is significantly lower than LFMD's 64.85% return.


BVS

YTD

-35.24%

1M

-11.11%

6M

-39.50%

1Y

34.92%

5Y*

N/A

10Y*

N/A

LFMD

YTD

64.85%

1M

69.29%

6M

59.06%

1Y

-33.82%

5Y*

39.55%

10Y*

32.30%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BVS vs. LFMD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BVS
The Risk-Adjusted Performance Rank of BVS is 8080
Overall Rank
The Sharpe Ratio Rank of BVS is 7171
Sharpe Ratio Rank
The Sortino Ratio Rank of BVS is 8585
Sortino Ratio Rank
The Omega Ratio Rank of BVS is 8282
Omega Ratio Rank
The Calmar Ratio Rank of BVS is 8383
Calmar Ratio Rank
The Martin Ratio Rank of BVS is 8181
Martin Ratio Rank

LFMD
The Risk-Adjusted Performance Rank of LFMD is 3636
Overall Rank
The Sharpe Ratio Rank of LFMD is 3333
Sharpe Ratio Rank
The Sortino Ratio Rank of LFMD is 4040
Sortino Ratio Rank
The Omega Ratio Rank of LFMD is 4040
Omega Ratio Rank
The Calmar Ratio Rank of LFMD is 2727
Calmar Ratio Rank
The Martin Ratio Rank of LFMD is 3838
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BVS vs. LFMD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bioventus Inc. (BVS) and LifeMD, Inc. (LFMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current BVS Sharpe Ratio is 0.51, which is higher than the LFMD Sharpe Ratio of -0.34. The chart below compares the historical Sharpe Ratios of BVS and LFMD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00December2025FebruaryMarchAprilMay
0.51
-0.34
BVS
LFMD

Dividends

BVS vs. LFMD - Dividend Comparison

Neither BVS nor LFMD has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BVS vs. LFMD - Drawdown Comparison

The maximum BVS drawdown since its inception was -95.18%, roughly equal to the maximum LFMD drawdown of -96.24%. Use the drawdown chart below to compare losses from any high point for BVS and LFMD. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%December2025FebruaryMarchAprilMay
-64.60%
-73.29%
BVS
LFMD

Volatility

BVS vs. LFMD - Volatility Comparison

The current volatility for Bioventus Inc. (BVS) is 19.00%, while LifeMD, Inc. (LFMD) has a volatility of 40.39%. This indicates that BVS experiences smaller price fluctuations and is considered to be less risky than LFMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%December2025FebruaryMarchAprilMay
19.00%
40.39%
BVS
LFMD

Financials

BVS vs. LFMD - Financials Comparison

This section allows you to compare key financial metrics between Bioventus Inc. and LifeMD, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00MAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
153.64M
64.25M
(BVS) Total Revenue
(LFMD) Total Revenue
Values in USD except per share items

BVS vs. LFMD - Profitability Comparison

The chart below illustrates the profitability comparison between Bioventus Inc. and LifeMD, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%80.0%85.0%AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
66.8%
85.3%
(BVS) Gross Margin
(LFMD) Gross Margin
BVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Bioventus Inc. reported a gross profit of 102.66M and revenue of 153.64M. Therefore, the gross margin over that period was 66.8%.

LFMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, LifeMD, Inc. reported a gross profit of 54.82M and revenue of 64.25M. Therefore, the gross margin over that period was 85.3%.

BVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Bioventus Inc. reported an operating income of 7.99M and revenue of 153.64M, resulting in an operating margin of 5.2%.

LFMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, LifeMD, Inc. reported an operating income of 1.02M and revenue of 64.25M, resulting in an operating margin of 1.6%.

BVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Bioventus Inc. reported a net income of -156.00K and revenue of 153.64M, resulting in a net margin of -0.1%.

LFMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, LifeMD, Inc. reported a net income of -106.27K and revenue of 64.25M, resulting in a net margin of -0.2%.